Pharmacy Perspectives in CLL/SLL: Navigating a Rapidly Evolving Treatment Landscape

Faculty

Provider Statement  

Provided by HMP Education, an HMP Global Company. 

Intended Learners

This conference is designed for oncology and hematology pharmacists, pharmacy technicians, residents, interns, and pharmacy researchers.

Learning Objectives

After completing this activity, participants should be able to:

• Review recent and emerging data from key studies in clinical and translational cancer research, including recently approved and expanded indications for immunotherapies and targeted therapies
• Discuss how to assess and select appropriate management strategies with adverse effects related to the use of targeted therapies, immunotherapy, and cytotoxic chemotherapy
• Identify ways to work collaboratively with other health care professionals to make evidence-based decisions designed to improve patient care

Activity Overview

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

Participants who have successfully completed the live version of this activity (Great Debates & Updates in Oncology Pharmacy 2021; July 22-24, 2021 or August 19-21, 2021) are not eligible to receive credit for this enduring webcast.

Release date: October 8, 2021
Expiration date: October 8, 2022
Estimated time to complete: 0.75 hour

There is no fee associated with this activity.

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

The evaluation is accessible after the activity via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

Continuing Education

In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity. 

International Recognition 

The following Countries, Regions, and Accrediting Bodies accept, or have reciprocity or mutual recognition of credits with the AMA/ACCME. Please contact the accrediting body to find out more information on submitting or converting your credits. 

• Bavarian Chamber of Physicians (Germany) 
• Bulgarian Union of Scientific Medical Societies (Bulgaria) 
• Canadian Medical Association (Canada) 
• Canadian Nurses Association (Canada) 
• EBAC® (European Board for Accreditation of Continuing Education for Health Professionals) 
• Federation of Royal Colleges of Physicians (UK) 
• French National Medical Council (France) 
• Italian Federation of Scientific Medical Societies (Italy) 
• National CME Commission of the Italian Ministry of Health (Italy) 
• Spanish Accreditation Council for CME (Spain) 
• UEMS-EACCME® (European Union of Medical Specialists) 

Disclaimers

The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a provider-patient relationship. Medical advice of any nature should be sought from an individual’s own provider. 

The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Global or any of its subsidiaries or affiliates. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering. 

Disclosure of Relevant Financial Relationships

HMP Education is an independent provider of continuing medical education. HMP Education has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority. 

In accordance with our disclosure policies, HMP Education is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real relevant financial relationship (conflicts of interest) between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME and CPME. 

Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose: 

1. Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and; 

2. Any investigational, off-label, or non-FDA approved content or discussion 

HMP Education has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner. 

Education has been independently peer-reviewed to validate content, mitigate identified financial relationships (conflicts of interest), and ensure: 

1. All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients. 

2. All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis. 

3. Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional. 

All relevant financial relationships have been mitigated. 

Faculty

The faculty has reported the following:

Kirollos Hanna, PharmD, BCPS, BCOP: Speakers’ Bureau–Seagen, Astellas, BeiGene, BMS, Exelixis, AbbVie; Consultant–Seagen, Astellas, Rigel; Advisory Board–Seagen, Astellas, AstraZeneca, GSK, Sanofi, G1 Therapeutics

Jessica Auten has nothing to disclose in relation to this activity.

CLINICAL REVIEWER

Jessica Auten, PharmD, BCOP
Clinical Pharmacy Specialist, Malignant Hematology
Director, PGY2 Oncology Pharmacy Residency
University of North Carolina Medical Center, UNC Eshelman School of Pharmacy
Chapel Hill, NC

PLANNING COMMITTEE

NACCME planners and staff include Ms. Browne, Ms. Conforti, Ms. Duda, Ms. Hines, Ms. Johnson,  Mr. Robbin, Mr. Sellers, and Ms. Tong

No NACCME planner or staff has disclosed a relevant financial relationship with any ineligible company (commercial interest).

ADA Statement 

HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity needs accommodation(s), please submit a request to contact the support team. 

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2024 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Grant Support

This activity is supported by an independent educational grant from BeiGene, Ltd.

Contact Us

For immediate assistance, please explore our HMP Education Help Center or chat with our Virtual CE Assistant who can answer most common questions related to claiming credits and the HMP Education website. If you have a question or grievance that cannot be answered by our Virtual CE assistant and Help Center, please submit a request to contact the support team. Our accreditation and compliance team will respond to your inquiry within 1 business day.